(ADMA) Adma Biologics complete technical analysis [charts+indicators] | Buy/Sell Adma Biologics | (ADMA) share price targets
Complete technical analysis of Adma Biologics (ADMA) by charts plus indicators, forecast predictions and share price targets for Adma Biologics (ADMA)
Adma Biologics trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-26 View latest technical analysis
10 day averaged volume of Adma Biologics is 3299790
| Date | Daily Closing Price | Open | High | Low | Volume |
| 26 Fri Jul 2024 | 13.16 | 13.27 | 13.35 | 12.94 | 0.849 times |
| 25 Thu Jul 2024 | 13.08 | 13.67 | 13.76 | 13.07 | 0.866 times |
| 24 Wed Jul 2024 | 13.58 | 13.74 | 13.84 | 13.47 | 0.652 times |
| 23 Tue Jul 2024 | 13.76 | 13.78 | 14.03 | 13.60 | 0.86 times |
| 22 Mon Jul 2024 | 13.75 | 13.50 | 13.95 | 13.47 | 1.237 times |
| 19 Fri Jul 2024 | 13.36 | 13.17 | 13.42 | 13.04 | 0.852 times |
| 18 Thu Jul 2024 | 13.05 | 13.37 | 13.54 | 12.87 | 1.149 times |
| 17 Wed Jul 2024 | 13.29 | 13.57 | 13.74 | 13.22 | 1.181 times |
| 16 Tue Jul 2024 | 13.73 | 13.49 | 13.84 | 13.47 | 1.231 times |
| 15 Mon Jul 2024 | 13.39 | 13.11 | 13.45 | 12.98 | 1.246 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 13.5 as stoploss in an intra day sell trade for a target of 12.58. However, stock will show a bullish move above 13.5.
Share price targets for Adma Biologics (ADMA)
| Target Type | Value |
| Downside Target | 5.32 |
| Downside Target | 5.90 |
| Downside Target | 6.52 |
| Downside Target | 6.68 |
| Downside Target | 9.63 |
| Downside Target | 11.01 |
| Downside Target | 11.68 |
| Downside Target | 12.80 |
| Downside Target | 12.87 |
| Downside Target | 12.94 |
| Upside Target | 13.84 |
| Upside Target | 14.03 |
Intraday share price targets for Adma Biologics (ADMA)
| Target Type | Value |
| Downside Intraday Target | 12.72 |
| Downside Intraday Target | 12.29 |
| Upside Intraday Target | 13.81 |
| Upside Intraday Target | 14.47 |
| Upside Intraday Target | 13.38 |
Weekly technical analysis of Adma Biologics (ADMA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 26 Fri Jul 2024 | 13.16 | 13.50 | 14.03 | 12.94 | 0.789 times |
| 19 Fri Jul 2024 | 13.36 | 13.11 | 13.84 | 12.87 | 1.25 times |
| 12 Fri Jul 2024 | 12.78 | 11.60 | 12.80 | 11.45 | 4.146 times |
| 05 Fri Jul 2024 | 11.46 | 11.45 | 11.50 | 11.01 | 0.532 times |
| 03 Wed Jul 2024 | 11.21 | 11.25 | 11.68 | 11.17 | 0.342 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adma Biologics (ADMA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 26 Fri Jul 2024 | 13.16 | 11.25 | 14.03 | 11.01 | 0.855 times |
| 28 Fri Jun 2024 | 11.18 | 9.64 | 11.27 | 9.63 | 0.983 times |
| 31 Fri May 2024 | 9.55 | 6.55 | 9.77 | 6.52 | 1.554 times |
| 30 Tue Apr 2024 | 6.52 | 6.61 | 6.68 | 5.90 | 0.672 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adma Biologics (ADMA)
Price action analysis of Adma Biologics ( (ADMA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adma Biologics ( (ADMA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Adma Biologics ( (ADMA) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adma Biologics ( (ADMA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adma Biologics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adma Biologics in short term but the sell signal is initial and weak.
Adma Biologics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Adma Biologics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Adma Biologics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.42 and Adma Biologics (ADMA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Adma Biologics (ADMA) stock. Volume based technical analysis of Adma Biologics (ADMA) stock is negative.
Adma Biologics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adma Biologics ( (ADMA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adma Biologics ( (ADMA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Adma Biologics ( (ADMA) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adma Biologics ( (ADMA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adma Biologics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adma Biologics in short term but the sell signal is initial and weak.
Adma Biologics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Adma Biologics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Adma Biologics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.42 and Adma Biologics (ADMA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Adma Biologics (ADMA) stock. Volume based technical analysis of Adma Biologics (ADMA) stock is negative.
Adma Biologics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.